• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Prevalence and QoL of Hand and Foot AD


Alexandra Golant, MD, delves into the prevalence and profound influence of hand and foot involvement in her patients, shedding light on the significant burden it imposes on their quality of life.

This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, serving as the medical director of the faculty practice and program director for the dermatology residency program.

Dr. Golant delves into the management of atopic dermatitis (AD) with a focus on hand and foot involvement. AD, the most prevalent inflammatory skin condition seen by dermatologists, often affects the hands and feet, causing year-round symptoms or flaring in response to environmental factors like cold or dry weather.

She notes a surge in hand involvement during the COVID-19 pandemic due to increased hand washing and sanitizer use, particularly impacting individuals with professions involving wet work. Quality of life considerations are paramount in AD treatment decisions, especially regarding hand and foot involvement, which significantly impact daily functioning.

Despite limited body surface area involvement, hand and foot AD can have a disproportionate effect on quality of life. Dr. Golant emphasizes the importance of understanding patients' experiences through dialogue, asking about how AD impacts daily life and addressing significant itch burdens, even in seemingly clear patients.

Patients with hand and foot involvement may experience profound itching, affecting sleep and overall well-being. Dr. Golant underscores the value of individualized treatment decisions guided by patient dialogue, aiming to alleviate symptoms and improve quality of life.

In summary, Dr. Golant highlights the complexities of managing AD, particularly when it involves the hands and feet, emphasizing personalized approaches to address symptoms and enhance patients' daily functioning.

Video synopsis is AI-generated and reviewed by Dermatology Times® editorial staff.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.